José Angel Arranz Arija

6PUBLICATIONS
58CO-AUTHORS
Immunogenetics (incl. genetic immunology)Innate immunityMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 24, 2025
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer.

Matthew D Galsky, Mark Kockx, Juliette Roels

|Jul 03, 2024
SEOM-GG clinical guidelines for the management of germ-cell testicular cancer (2023).

José Angel Arranz Arija, Xavier García Del Muro, Raquel Luque Caro

|Mar 21, 2024
A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer: Results from CYCLONE 1.

Neeraj Agarwal, Daniel Castellano, Teresa Alonso-Gordoa

|Jul 25, 2020
Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis.

Miguel Ángel Amor-García, Roberto Collado-Borrell, Vicente Escudero-Vilaplana

|Jul 25, 2018
Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss.

Johann S de Bono, Ugo De Giorgi, Daniel Nava Rodrigues

Pageof 1